Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03209557 · ClinicalTrials.gov registry record · NA
Pilot Trial of Using SmokeBeat to Monitor and Increase Smoking Abstinence in Pregnant Women
A NA study of Pregnancy Related and Tobacco Use Cessation, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT03209557: Completed NA study of Pregnancy Related and Tobacco Use Cessation, sponsored by University of Pennsylvania.
NCT03209557 is a NA study of Pregnancy Related and Tobacco Use Cessation that has completed, run by University of Pennsylvania. The registered enrollment target is 32 participants, below the 1,963-participant average among 99 other Pregnancy Related trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03209557, a NA study of Pregnancy Related and Tobacco Use Cessation, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators will assess the feasibility of implementing a randomized control trial of a behavioral intervention that uses smartwatch technology to monitor smoking behavior with texts aimed at reducing smoking in pregnant women who smoke. Investigators will compare the cessation rate of pregnant women who receive usual care through programs aimed at reducing smoking with pregnant women who receive usual care and are using the SmokeBeat app with a smartwatch.
Primary Outcome
Quit rates in control vs. intervention group as determined by weekly cotinine testing.
Conditions Studied
Interventions
- OTHER SmartWatch SmokeBeat Application
Study Locations (1)
Pennsylvania
- Lancaster General Hospital - Lancaster
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2017-07-05 |
| Est. Completion | 2019-04-30 |
| Phase | NA |
What the finished NCT03209557 record still lists
NCT03209557 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,963-participant average among 99 other Pregnancy Related trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 1 intervention - of which SmartWatch SmokeBeat Application is the first listed.
NCT03209557 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03209557 about?
NCT03209557 is a clinical study titled "Pilot Trial of Using SmokeBeat to Monitor and Increase Smoking Abstinence in Pregnant Women". Investigators will assess the feasibility of implementing a randomized control trial of a behavioral intervention that uses smartwatch technology to monitor smoking behavior with texts aimed at reducing smoking in pregnant women who smoke. Investigators will compare the cessation rate of pregnant wo...
What is the current status of trial NCT03209557?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2017-07-05. Estimated completion is 2019-04-30.
What conditions does trial NCT03209557 study?
This clinical trial studies the following conditions: Pregnancy Related, Tobacco Use Cessation.
What interventions are being tested in trial NCT03209557?
The interventions under investigation include: SmartWatch SmokeBeat Application (OTHER).
Who is sponsoring clinical trial NCT03209557?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03209557 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03209557's enrollment target sits among peer trials
32 88th of 99 higher than 12 of 99 other Pregnancy Related trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Accountability for Care Through Undoing Racism & Equity for Moms
RECRUITING · NA
-
Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
MAMA Tot - Healthy Weight Parallel Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI